ES8707946A1 - Un procedimiento para la preparacion de derivados de furanona. - Google Patents

Un procedimiento para la preparacion de derivados de furanona.

Info

Publication number
ES8707946A1
ES8707946A1 ES556467A ES556467A ES8707946A1 ES 8707946 A1 ES8707946 A1 ES 8707946A1 ES 556467 A ES556467 A ES 556467A ES 556467 A ES556467 A ES 556467A ES 8707946 A1 ES8707946 A1 ES 8707946A1
Authority
ES
Spain
Prior art keywords
furanone derivatives
alk
chem
straight
double
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES556467A
Other languages
English (en)
Other versions
ES556467A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of ES556467A0 publication Critical patent/ES556467A0/es
Publication of ES8707946A1 publication Critical patent/ES8707946A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/60—Two oxygen atoms, e.g. succinic anhydride
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

PROCEDIMIENTO PARA LA PREPARACION DE DERIVADOS DE FURANONA, DE FORMULA GENERAL (I). CONSISTE EN HACER REACCIONAR UN ALDEHIDO DE FORMULA GENERAL (II), CON ACIDO GLICOXILICO E HIDROCLORURO DE MORFOLINA, EN LAS QUE R1 ES UN RADICAL HIDROCARBONA MONOVALENTE C8-24, DE CADENA LINEAL O RAMIFICADA, QUE CONTIENE ENLACES DOBLES O TRIPLES. DE APLICACION EN EL TRATAMIENTO DE LA INFLAMACION, ASMA, ALERGIAS Y CUALQUIER OTRA ENFERMEDAD RELACIONADA O CAUSADA POR UN EXCESO DE PROSTAGLANDINAS, TROMBOXANOS O LEUCOTRIENOS.
ES556467A 1985-07-01 1986-06-23 Un procedimiento para la preparacion de derivados de furanona. Expired ES8707946A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US75080185A 1985-07-01 1985-07-01

Publications (2)

Publication Number Publication Date
ES556467A0 ES556467A0 (es) 1987-09-01
ES8707946A1 true ES8707946A1 (es) 1987-09-01

Family

ID=25019225

Family Applications (1)

Application Number Title Priority Date Filing Date
ES556467A Expired ES8707946A1 (es) 1985-07-01 1986-06-23 Un procedimiento para la preparacion de derivados de furanona.

Country Status (13)

Country Link
EP (1) EP0209274A3 (es)
JP (1) JPS625976A (es)
KR (1) KR870000908B1 (es)
CN (1) CN86104450A (es)
AU (1) AU583930B2 (es)
DK (1) DK301886A (es)
ES (1) ES8707946A1 (es)
HU (1) HUT44530A (es)
IL (1) IL79212A0 (es)
NZ (1) NZ216647A (es)
PH (1) PH22938A (es)
PT (1) PT82850B (es)
ZA (1) ZA864674B (es)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4952605A (en) * 1983-08-03 1990-08-28 The Regents Of The University Of California Manoalide analogs
US4789749A (en) * 1984-06-18 1988-12-06 The Regents Of The University Of California Manoalide analogs
US5171863A (en) * 1987-06-08 1992-12-15 Allergan, Inc. Intermediates for preparing 4-substituted 2-5(H)-furanones as anti-inflammatory agents
US5089485A (en) * 1988-11-18 1992-02-18 Allergan, Inc. Anti-inflammatory furanones
CA1329390C (en) * 1987-06-08 1994-05-10 John N. Bonfiglio Anti-inflammatory furanones
US5037811A (en) * 1990-04-17 1991-08-06 Allergan, Inc. 4-(oxygen, sulfur or nitrogen substituted)-methyl 5-hydroxy-2(5H)-furanones as anti-inflammatory agents
US5081147A (en) * 1990-03-15 1992-01-14 Allergan, Inc. 4-(1-hydroxy-2-substituted amino)ethyl-5-hydroxy-2(5H)-furanones as anti-inflammatory agents
US5059611A (en) * 1988-11-18 1991-10-22 Allergan, Inc. Anti-inflammatory 5-hydroxy-2-furanones
US5134128A (en) * 1987-06-08 1992-07-28 Allergan, Inc. Anti-inflammatory furanones
US5043457A (en) * 1990-04-17 1991-08-27 Allergan, Inc. 2(5H)-furanones substituted in the 3 position, as Ca2+ channel antagonists and anti-inflammatory agents
US5026725A (en) * 1988-06-06 1991-06-25 American Home Products Corporation Inhibition of bone loss by 4-substituted-5-hydroxy-2(5H)-furanones
US4916241A (en) * 1988-06-06 1990-04-10 American Home Products Corporation Inhibition of bone loss by 4-substituted-5-hydroxy-2(5H)-furanones
US4957917A (en) * 1989-10-25 1990-09-18 Allergan, Inc. Anti-inflammatory furanones
US5045564A (en) * 1988-12-07 1991-09-03 Allergan, Inc. Anti-inflammatory 2-furanones
DE3906214A1 (de) * 1989-02-28 1990-08-30 Boehringer Mannheim Gmbh Verwendung von macrolactone als antiallergica
JP2790335B2 (ja) * 1989-09-20 1998-08-27 株式会社クラレ 共役γ―オキシブテノライド化合物およびこれを有効成分とする抗潰瘍剤
US5112853A (en) * 1989-11-20 1992-05-12 Allergan, Inc. Anti-inflammatory furanone compounds
US5258400A (en) * 1989-11-20 1993-11-02 Allergan, Inc. Anti-inflammatory furanone compounds
US5081261A (en) * 1990-03-23 1992-01-14 Allergan, Inc. 4-(1-hydroxy-2-N-substituted sulfonamido) ethyl-5-hydroxy-2(5H)-furanones and 4-(N-substituted sulfonamido)-2-ethenyl-5-hydroxy-2(5H)-furanones as anti-inflammatory agents
US5013850A (en) * 1990-03-30 1991-05-07 Allergan, Inc. 4-ethyl and 4-ethenyl-5-hydroxy-2(5H)-furanones substituted on alpha carbon of the ethyl or ethenyl side chain with a long chain alkyl group and on the beta carbon with a polar group, as anti-inflammatory agents
US5183906A (en) * 1991-04-30 1993-02-02 Allergan, Inc. 2- and 5-alkyl and phenyl substituted 4-(1-hydroxy, 1-acyloxy or 1-carbamoyloxy)-5-hydroxy-2 (5h)-furanones as anti-inflammatory agents
US5225571A (en) * 1991-04-30 1993-07-06 Allergan, Inc. Substituted dihydroxy-bis-[5-hydroxy-2(5H)-furanone-4-yl]-alkanes as anti-inflammatory agents
US5171864A (en) * 1991-08-30 1992-12-15 Allergan, Inc. Di-(5-hydroxy-2(5H)-2-oxo-4-furyl)methyl-alpha,omega alkane-dioates and N,N-bis-(5-hydroxy-2(5H)-2-oxo-4-furyl)methyl-alpha,omega-dialkanoic acid amides as anti-inflammatory agents
US5169963A (en) * 1991-08-30 1992-12-08 Allergan, Inc. Di-(5-hydroxy-2(5H)2-oxo-4-furyl)alkylmethyl-alpha,omega alkanedioates and N,N-bis-(5-hydroxy-2(5H)2-oxo-4-furyl)alkylmethyl-alpha,omega-dialkanoic acid amides as anti-inflammatory agents
US5268387A (en) * 1992-04-24 1993-12-07 Allergan, Inc. Pharmaceutical compositions and method for administering 3 and 4-substituted 2(5H)-furanones to a mammal for inhibiting bone loss
US5451686A (en) * 1994-04-15 1995-09-19 Allergan, Inc. 3 and 5 alkyl and phenyl 4-(hydroxy or acyloxy)-alkyl substituted 2(5H)-furanones as anti-inflammatory agents
JP5381942B2 (ja) 2010-09-17 2014-01-08 オムロンヘルスケア株式会社 電子体温計およびその製造方法
SG11202102873WA (en) 2018-09-25 2021-04-29 Schlumberger Technology Bv Piston load ring seal configurations

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57149283A (en) * 1981-03-09 1982-09-14 Fujisawa Pharmaceut Co Ltd Long-chain fatty acid lactol
DE3472958D1 (en) * 1983-08-03 1988-09-01 Univ California Synthetic analgesic and/or anti-inflammatory derivatives of manoalide
US4447445A (en) * 1983-08-03 1984-05-08 The Regents Of The University Of Calif. Manoalide, an anti-inflammatory analgesic marine natural product
US4616089A (en) * 1983-08-03 1986-10-07 University Of California Synthetic anti-inflammatory derivatives of manoalide
US4789749A (en) * 1984-06-18 1988-12-06 The Regents Of The University Of California Manoalide analogs

Also Published As

Publication number Publication date
IL79212A0 (en) 1986-09-30
CN86104450A (zh) 1986-12-31
PT82850B (en) 1988-05-06
HUT44530A (en) 1988-03-28
NZ216647A (en) 1989-04-26
JPS625976A (ja) 1987-01-12
KR870000908B1 (ko) 1987-05-06
KR870001187A (ko) 1987-03-12
AU583930B2 (en) 1989-05-11
ES556467A0 (es) 1987-09-01
EP0209274A3 (en) 1987-07-22
AU5934386A (en) 1987-01-08
DK301886A (da) 1987-01-02
PH22938A (en) 1989-02-03
ZA864674B (en) 1988-02-24
EP0209274A2 (en) 1987-01-21
PT82850A (en) 1986-07-01
DK301886D0 (da) 1986-06-26

Similar Documents

Publication Publication Date Title
ES8707946A1 (es) Un procedimiento para la preparacion de derivados de furanona.
AU577087B2 (en) Flavoured oral hydrogen peroxide gel composition
AU575637B2 (en) Oral hygiene compositions
AU1650388A (en) Tetrazole intermediates to antihypertensive compounds
AU560028B2 (en) Pyridine-n-oxide derivatives
NZ226354A (en) Azaspirane derivatives and pharmaceutical compositions
IL112495A0 (en) Phenylacetic acid derivatives, their preparation and compositions containing them
ES8801643A1 (es) Un metodo para producir nuevos derivados del acido ascorbico
ES2176698T3 (es) Nuevos derivados de la eritromicina, su procedimiento de preparacion y su aplicacion como medicamentos.
AU4569185A (en) Gel-type shampoo compositions
IT1264563B1 (it) Composti fotocromatici e metodo per la loro preparazione
AU547111B2 (en) Tricyclic substituted piperidylidene derivatives
AU8062487A (en) New substituted cephalosporin sulfones as anti-inflammatory and antidegenerative agents
ES8705453A1 (es) Un procedimiento para la preparacion de derivados de cefalosporina.
WO1995025091A3 (en) Nipecotic acid derivatives as antithrombic compounds
ES8604604A1 (es) Un procedimiento para la produccion de 3,3",4"-tri-o-acilespiramicina i"-.
AU4524285A (en) Antitussive and mucus regulating 2-substituted thiazolidines
GB8502258D0 (en) Organic compounds
MX170732B (es) Composicion de derivados de succinimida y su uso
AU2234588A (en) Administration of extremely low dosages of dideoxynucleoside analogs for treating or preventing AIDS in subjects
ES8607935A1 (es) Un procedimiento de preparar un derivado de ariltio-piridi- nil-alcanol
GR3000305T3 (en) Improved antiinflammatory compositions and methods
GR3007079T3 (es)
ES2002207A6 (es) Un metodo para producir derivados de glucosilmoranolina
AU591950B2 (en) Novel 16,17-acetalsubstituted pregnane 21-OIC acid derivatives